Hydrogel nanoarchitectonics: an evolving paradigm for ultrasensitive biosensing
The integration of nanoarchitectonics and hydrogel into conventional biosensing platforms
offers the opportunities to design physically and chemically controlled and optimized soft …
offers the opportunities to design physically and chemically controlled and optimized soft …
Recent progress in discovering the role of carotenoids and their metabolites in prostatic physiology and pathology with a focus on prostate cancer—A review—Part I …
J Dulińska-Litewka, Y Sharoni, P Hałubiec… - Antioxidants, 2021 - mdpi.com
Among the vast variety of plant-derived phytochemicals, the group of carotenoids has
continuously been investigated in order to optimize their potential application in the area of …
continuously been investigated in order to optimize their potential application in the area of …
MicroRNA-375 is a therapeutic target for castration-resistant prostate cancer through the PTPN4/STAT3 axis
J Gan, S Liu, Y Zhang, L He, L Bai, R Liao… - … & molecular medicine, 2022 - nature.com
The functional role of microRNA-375 (miR-375) in the development of prostate cancer (PCa)
remains controversial. Previously, we found that plasma exosomal miR-375 is significantly …
remains controversial. Previously, we found that plasma exosomal miR-375 is significantly …
miR-24 regulates apoptosis by targeting the open reading frame (ORF) region of FAF1 in cancer cells
Background microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs
at the post-transcriptional stage. Several studies have shown that miRNAs modulate gene …
at the post-transcriptional stage. Several studies have shown that miRNAs modulate gene …
[HTML][HTML] Role of androgens and the androgen receptor in epithelial-mesenchymal transition and invasion of prostate cancer cells
ML Zhu, N Kyprianou - The FASEB Journal, 2010 - ncbi.nlm.nih.gov
Androgens are functionally required for the normal growth of the prostate gland and in
prostate tumor development and progression. Epithelial-mesenchymal-transition (EMT) is an …
prostate tumor development and progression. Epithelial-mesenchymal-transition (EMT) is an …
Inhibition of Ca2+-activated Cl− channel ANO1/TMEM16A expression suppresses tumor growth and invasiveness in human prostate carcinoma
W Liu, M Lu, B Liu, Y Huang, KW Wang - Cancer letters, 2012 - Elsevier
The etiology of prostatic adenocarcinoma remains unclear. Prostate cancer cells of varying
metastatic potential and apoptotic resistance show altered expression of plasma membrane …
metastatic potential and apoptotic resistance show altered expression of plasma membrane …
PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling
Background PCA3 is a non-coding RNA (ncRNA) that is highly expressed in prostate cancer
(PCa) cells, but its functional role is unknown. To investigate its putative function in PCa …
(PCa) cells, but its functional role is unknown. To investigate its putative function in PCa …
Growth inhibition and apoptosis in cancer cells induced by polyphenolic compounds of Acacia hydaspica: Involvement of multiple signal transduction pathways
Acacia hydaspica R. Parker is known for its medicinal uses in multiple ailments. In this study,
we performed bioassay-guided fractionation of cytotoxic compounds from A. hydaspica and …
we performed bioassay-guided fractionation of cytotoxic compounds from A. hydaspica and …
Shikonin reduces growth of docetaxel-resistant prostate cancer cells mainly through necroptosis
SD Markowitsch, KM Juetter, P Schupp, K Hauschulte… - Cancers, 2021 - mdpi.com
Simple Summary Prostate carcinoma (PCa) is the most common tumor in men with an
increasing age-associated risk. Several therapy strategies, one of which is docetaxel (DX) …
increasing age-associated risk. Several therapy strategies, one of which is docetaxel (DX) …
[PDF][PDF] RETRACTED ARTICLE: Induction of apoptosis and autophagy via sirtuin1-and PI3K/Akt/mTOR-mediated pathways by plumbagin in human prostate cancer …
ZW Zhou, XX Li, ZX He, ST Pan, Y Yang… - Drug design …, 2015 - Taylor & Francis
Zhou Z, Li X, He Z, et al. Drug Des Devel Ther. 2015; 9: 1511–1554. The Editor and
Publisher of Drug Design, Development and Therapy wish to retract the published article …
Publisher of Drug Design, Development and Therapy wish to retract the published article …